GREY:BITKF - Post by User
Comment by
dimar66on Dec 31, 2013 1:59pm
151 Views
Post# 22049335
RE:RE:News
RE:RE:NewsI don't see this as dilutive because we are trading asets for shares, the fact that the deal was at a premium to market and was almost all in shares tells me that IBL management see this as a good investment. There must be a synergy there that has created expectations.
$75,000 in cash, and by the issuance of 36,000,000 common shares of Biosign at an ascribed price of $0.05 per share, being a premium to the market price at the execution date of the SPA.